OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
Dan Yang, Yang He, Bo Wu, et al.
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
Juan Zou, Yukun Li, Nianchun Liao, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 57

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Samantha Bruno, Andrea Ghelli Luserna di Rorà, Roberta Napolitano, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 57

Protein‐protein interaction networks as miners of biological discovery
Steven Wang, Runxin Wu, Jiaqi Lü, et al.
PROTEOMICS (2022) Vol. 22, Iss. 15-16
Closed Access | Times Cited: 44

miR-3587 Inhibitor Attenuates Ferroptosis Following Renal Ischemia-Reperfusion Through HO-1
Wenqiang Tao, Fen Liu, Jianguo Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 34

Novel gene signatures for prognosis prediction in ovarian cancer
Mingyang Bao, Lihua Zhang, Yue‐Qing Hu
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 17, pp. 9972-9984
Open Access | Times Cited: 36

A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC–OXPHOS axis
Ruibin Jiang, Zhongjian Chen, Maowei Ni, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11

MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways
Fei Wang, Han Zhang, Xiru Liu, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access

miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A
Songwei Feng, Shanhui Luo, Chenchen Ji, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 32

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
Tianshui Sun, Fangfang Bi, Zhuonan Liu, et al.
Aging (2020) Vol. 12, Iss. 13, pp. 13281-13296
Open Access | Times Cited: 28

Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway
Yang Wang, Shiyang Shen, Lei Liu, et al.
Journal of Ethnopharmacology (2021) Vol. 282, pp. 114581-114581
Open Access | Times Cited: 24

Explore Key Genes and Mechanisms Involved in Colon Cancer Progression Based on Bioinformatics Analysis
Yongting Lan, Xiuzhen Yang, Yu-Lian Wei, et al.
Applied Biochemistry and Biotechnology (2024)
Closed Access | Times Cited: 3

Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology
Andrzej Nowicki, Magdalena Kulus, Maria Wieczorkiewicz, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4178-4178
Open Access | Times Cited: 22

Ginsenoside Rf inhibits human tau proteotoxicity and causes specific LncRNA, miRNA and mRNA expression changes in Caenorhabditis elegans model of tauopathy
Shuai Zhang, Hui Wang, Jing Wang, et al.
European Journal of Pharmacology (2022) Vol. 922, pp. 174887-174887
Closed Access | Times Cited: 16

Emerging role of circular RNAs in the pathogenesis of ovarian cancer
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15

An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma
Zhiyun Xu, Shi Wang, Zhijian Ren, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15

Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis
Qingsong Zeng, Cunjian Yi, Jinzhi Lu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 7, pp. 9024-9040
Open Access | Times Cited: 7

Genetic deviation associated with photodynamic therapy in HeLa cell
Asiye Gök Yurttaş, Zehra Okat, Tuğba Elgün, et al.
Photodiagnosis and Photodynamic Therapy (2023) Vol. 42, pp. 103346-103346
Closed Access | Times Cited: 7

Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments
Xiaoying Chang, Dan Li, Chang Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 16

Identification of potential core genes in esophageal carcinoma using bioinformatics analysis
Xiaojie Yang, Mengyue Tian, Weiguang Zhang, et al.
Medicine (2021) Vol. 100, Iss. 27, pp. e26428-e26428
Open Access | Times Cited: 15

The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis
Binkai Yang, Tian Wang, Na Li, et al.
Advances in Therapy (2021) Vol. 38, Iss. 10, pp. 5178-5190
Closed Access | Times Cited: 15

Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma
Rui Zhou, Denghua Liu, Jing Zhu, et al.
Medicine (2020) Vol. 99, Iss. 42, pp. e22434-e22434
Open Access | Times Cited: 15

Increased UBE2L6 regulated by type 1 interferon as potential marker in TB
Jiao Gao, Chonghui Li, Wenjing Li, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 24, pp. 11232-11243
Open Access | Times Cited: 14

KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease
Qiang Zhang, Yue Zheng, Meng Ning, et al.
BMC Cardiovascular Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 13

Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating LGALS1
Yong Chen, Yuan Fang, Li Li, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top